A batch of over 12,000 human blood plasma has been found contaminated with HIV in China and the government has launched a probe into the latest medical scandal in the country.
A batch of Intravenous immunoglobulin, a product made of human blood plasma to treat a weak immune system, was tested positive for HIV. The drug was manufactured by Shanghai-based company Shanghai Xinxing Pharmaceutical.
China's National Health Commission (NHC), which launched an investigation into the matter, said experts believe the risk of HIV infection in patients using the drug was very low.
According to Beijing News, a news portal in Chinese, a total of 12,226 50ml bottles of the product were issued and approved by the Shanghai food and drug testing institute under the Shanghai Food and Drug Administration.
The batches of the product expire in June 2021.
The NHC ordered the suspension the use of the batches of products by the hospitals.
"According to international relevant literature reports, combined with the characteristics of the production process of the drug inactivated virus and the PH value of the product, experts believe that the risk of HIV infection in patients using the drug is very low," the NHC said in a statement.
This is the third big health scandal hitting China since July 2018 when hundreds of children were administered expired polio vaccines.
This week some 29 children were given wrong vaccines.
--IANS
gsh/soni/
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
